Ameresco is supported by growth, margin gains, and data center demand, but high debt and weak cash flow limit its upside. See ...
The €167 analyst price target for ACT is 28% less than our estimate of fair value Today we'll do a simple run through of a valuation method used to estimate the attractiveness of AlzChem Group AG (ETR ...
Key Insights The projected fair value for EKF Diagnostics Holdings is UK£0.44 based on 2 Stage Free Cash Flow to ...
Blue Owl Capital terminated its merger with Blue Owl Capital Corporation II, leading to a 20% discount to net asset value.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback